Exp Clin Endocrinol Diabetes 1996; 104(1): 1-9
DOI: 10.1055/s-0029-1211414

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Sulfonylurea receptors and mechanism of sulfonylurea action

U. Panten, M. Schwanstecher, C. Schwanstecher
  • Institut für Pharmakologie und Toxikologie, Technische Universität Braunschweig, Germany
Further Information

Publication History

Publication Date:
15 July 2009 (online)


Binding of hypoglycemic sulfonylureas and their analogues to the sulfonylurea receptor in the β-cell plasma membrane mediates closure of the ATP-sensitive K+-channel (KATP-channel) and thereby stimulation of insulin release. The sulfonylurea receptor is a member of the traffic ATPase family with two intracellular nucleotide binding folds. The receptor binding site for hypoglycemic drugs is located at the cytoplasmic face of the plasma membrane. Mutations in the sulfonylurea receptor gene have been detected which cause familial hyper-insulinism. Non-β-cell sulfonylurea receptors do not contribute to the therapeutic benefit of sulfonylureas, but might be involved in presumed adverse effects of sulfonylureas in the cardiovascular and the central nervous system.